Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial-Reference-Cited by-同舟云学术

Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial

Published:2014-11-17 Issue:11 Volume:9 Page:e113371
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Massacesi Luca,Tramacere Irene,Amoroso Salvatore,Battaglia Mario A.,Benedetti Maria Donata,Filippini Graziella,La Mantia Loredana,Repice Anna,Solari Alessandra,Tedeschi Gioacchino,Milanese Clara

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Double-masked trial of azathioprine in multiple sclerosis. british and dutch multiple sclerosis azathioprine trial group;Lancet,1988

2. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis;GW Ellison;Neurology,1989

3. The efficacy of azathioprine in relapsing-remitting multiple sclerosis;DE Goodkin;Neurology,1991

4. A double blind study on azathioprine efficacy in multiple sclerosis: Final report;C Milanese;J Neurol,1993

5. Disease-modifying drugs for multiple sclerosis: A rapid and systematic review;A Clegg;Health Technol Assess,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sclerosi multipla: trattamenti di base;EMC - Neurologia;2024-08

2. Genotyping of rs1127354 and rs7270101 SNPs in Multiple Sclerosis Patients: Correlation with ITPA Gene Expression;Jentashapir Journal of Cellular and Molecular Biology;2024-07-03

3. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07

4. Disease-modifying therapies as positive predictors of quality of life for Sudanese patients with multiple sclerosis: a cross-sectional study;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-06-20

5. Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-04